Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Upcoming events – Axsome’s depression data and Eli Lilly’s IL-10 in lung cancer
EP Vantage
Fri, 12/13/19 - 11:02 am
Tags:
Axsome Therapeutics, AXS-05, treatment-resistant depression, depression, Eli Lilly, pegilodecakin, lung cancer
Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Tue, 12/10/19 - 11:53 pm
Tags:
Merck, Eli Lilly, AbbVie, JNJ, Imbruvica, ARQ 531, LOXO-305, CLL, ASH2019
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
Fierce Biotech
Sun, 12/8/19 - 10:20 pm
Tags:
Eli Lilly, Loxo Oncology, ASH2019, CLL
Lilly puts its cancer future in Loxo's hands
Biopharma Dive
Thu, 12/5/19 - 10:20 am
Tags:
Eli Lilly, Loxo Oncology, M&A, cancer, R&D, oncology
Lilly putting $400M into U.S. diabetes production, adding 100 jobs
Fierce Pharma
Wed, 11/20/19 - 10:24 am
Tags:
Eli Lilly, diabetes, drug manufacturing, hirings
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
Mon, 11/18/19 - 10:29 am
Tags:
diabetes, AHA, heart failure, Eli Lilly, Boehringer Ingelheim, Jardiance, clinical trials
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
Zacks.com
Thu, 11/14/19 - 10:25 am
Tags:
Eli Lilly, Boehringer Ingelheim, FDA, Jardiance, type 1 diabetes
Eli Lilly-backed biotech grabs $100M to dispatch antibody-oligonucleotide conjugates after muscular dystrophy
Endpoints
Wed, 11/13/19 - 10:09 am
Tags:
myotonic muscular dystrophy, Eli Lilly, R&D, Avidity
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Pharmaceutical Business Review
Wed, 11/13/19 - 10:02 am
Tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, heart failure
Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data
Fierce Pharma
Tue, 11/12/19 - 09:51 am
Tags:
Eli Lilly, Taltz, psoriatic arthritis, AbbVie, Humira
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Pharmaforum
Tue, 11/5/19 - 10:21 am
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, diabetes, type 2 diabetes
Dogs help Eli Lilly scientists identify new osteoarthritis target
Fierce Biotech
Fri, 11/1/19 - 10:25 am
Tags:
osteoarthritis, Eli Lilly, drug discovery, R&D, osteoarthritis in dogs
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Fierce Pharma
Thu, 10/24/19 - 10:55 am
Tags:
Eli Lilly, Trulicity, Taltz, immunology, type 2 diabetes
Eli Lilly CEO Says Drugmaker Won’t Rehash Old Alzheimer’s Data
Bloomberg
Wed, 10/23/19 - 10:29 pm
Tags:
Eli Lilly, Biogen, Alzheimer's disease, David Ricks
Lilly USA diabetes chief Enrique Conterno bows out after 27 years
Fierce Pharma
Wed, 10/23/19 - 03:00 pm
Tags:
Eli Lilly, diabetes, Enrique Conterno
Eli Lilly (LLY) Surpasses Q3 Earnings Estimates
Yahoo/Zacks.com
Wed, 10/23/19 - 09:31 am
Tags:
Eli Lilly, earnings
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Yahoo/Benzinga
Sun, 10/20/19 - 05:18 pm
Tags:
earnings, Eli Lilly, Alexion, Gilead Sciences, Biomarin, Edwards Lifesciences, Baxter International, Integra LifeSciences, Phathom Pharmaceuticals, IPOs, Foamix, Eton Pharmaceuticals, Melinta Therapeutics, Ligand Pharmaceuticals
Lilly cancer drug pipeline hit by trial setback
Biopharma Dive
Wed, 10/16/19 - 12:21 pm
Tags:
Eli Lilly, pegilodecakin, immunotherapy, pancreatic cancer, ARMO BioSciences
Eli Lilly to shutter neuroscience R&D center next year
Fierce Biotech
Tue, 10/15/19 - 09:44 am
Tags:
Eli Lilly, UK, layoffs, R&D
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
Xconomy
Fri, 10/11/19 - 10:50 pm
Tags:
Eli Lilly, migraines, Lasmiditan, FDA, Reyvow

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.